🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Medical Honey for Wound Treatment in Intensive Care. (MICARéa) Randomized, Controlled, Single-center Pilot Study.

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Angers
NCT06150326 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Wound management is a real public health issue in France. To date, a wide range of devices exists to treat these wounds, depending on their nature and stage of evolution. Honey has been proposed for the care of wounds and is effective in reducing the surface of wounds and the pain perceived by patients. Inanition, its use is very simple compared to usual care, requiring different types of dressing accross time. In the intensive care unit, patients are prone to suffering or developing numerous types of wound, but the interest of honey has not been investigated yet. We propose a prospective, monocentric, randomized, single-blind, controlled clinical trial to assess the efficacy of managing acute cutaneous wounds with honey (Activon®) compared with standard care, in intensive care patients. The primary endpoint is the percentage of wound surface area reduction measured at 15 days from incl

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Hospitalization in surgical intensive care unit A -USC PTO CHU ANGERS * Informed consent signed by patient or relative (or emergency inclusion procedure) * Patient with one or more wounds ≥ 4 cm2, evolving for less than 8 days, including: stage 2, 3, 4 pressure sores, lacerations, ulcers, dermabrasions and scar disunions. Exclusion Criteria: * Patients with honey intolerance/allergy to bee stings * Patients with wounds lasting more than 8 days * Patient with a bleeding wound, * Patient with a tunneled wound * Patients with chronic dermatoses * Patient with an estimated life expectancy \< 15 days * Expected discharge ≤48 hours. * No affiliation to a French social security scheme or beneficiary of such a scheme. * Pregnant, breast-feeding or parturient woman * Person deprived of liberty by judicial or administrative decision * Person subject to a legal protection measure
💊

What it tests

  • medical honey Activon® 25g Tube
  • standard of care
📍

Where

1 site
Angers University Hospital, surgical reanimation
Angers, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy